Torrent Pharma, Pharmaceuticals sector

Torrent Pharma Stock - Weekly review and sector check after FDA nod report

19.06.2026 - 18:58:25 | ad-hoc-news.de

Torrent Pharma stock closes the week with a muted move while local media flag an FDA approval for valsartan tablets. Here is how the pharmaceutical group sits in the broader Indian pharma sector after a busy week for healthcare names.

Torrent Pharma, Pharmaceuticals sector, Weekly review
Torrent Pharma, Pharmaceuticals sector, Weekly review

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 18:57 IST. Details in the imprint.

Torrent Pharma (INE685A01028) remains one of the more richly valued Indian pharma names after a largely sideways week for the shares. Sector data from Indian business portals show only modest moves, even as local reports highlight a recent US FDA approval for valsartan tablets that strengthens its US generics portfolio.

Go deeper

More background and price data on Torrent Pharma stock

Key figures, news and filings on Torrent Pharma help frame this week's muted share performance in the context of the broader Indian pharma sector.

How the week played out

According to Indian quote services, Torrent Pharma shares changed hands around INR 4,430 on the National Stock Exchange on Friday afternoon, down roughly 0.3% for the session and trading not far from this month's highs.

Over the past five trading days, the stock has largely oscillated in a band between about INR 4,400 and INR 4,485, with no single day showing an outsized move versus the broader Nifty Pharma index.

Position in the pharma sector

Sector snapshots show Torrent Pharma valued at a price-earnings ratio near 70 and a price-book multiple above 8, placing it toward the upper end of the Indian pharma peer group on valuation metrics.

Its 52-week trading range stretches from roughly INR 3,140 at the low to around INR 4,713 at the high, underlining robust investor interest in the name over the past year compared with several domestic rivals.

The business behind the stock

Torrent Pharma generates most of its revenue from branded generics, with key therapeutic areas including cardiovascular, central nervous system and gastro-intestinal treatments, and it maintains a meaningful presence in India and select international markets including the US.

Where the stock trades today

The shares of Torrent Pharma (INE685A01028) trade on the National Stock Exchange at INR 4,430.80 as of 06/19/2026, 15:30 IST.

Torrent Pharma stock at a glance

  • Company: Torrent Pharmaceuticals Ltd
  • ISIN: INE685A01028
  • WKN: 125545
  • Ticker: TORNTPHARM
  • Venue: NSE
  • Price (as of 06/19/2026, 15:30 IST): 4,430.80 INR
  • Market cap: 1,49,000 crore INR (as of 06/19/2026)
  • Sector / Industry: Healthcare / Pharmaceuticals
  • Index membership: Nifty 200, Nifty Healthcare Index (selection)
  • Next earnings date: not officially scheduled

More on Torrent Pharma stock across social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | boerse | 69584387 |